• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从豚鼠红细胞基质中纯化经典C3转化酶C4b,2a的衰变加速因子。

Purification from guinea pig erythrocyte stroma of a decay-accelerating factor for the classical c3 convertase, C4b,2a.

作者信息

Nicholson-Weller A, Burge J, Austen K F

出版信息

J Immunol. 1981 Nov;127(5):2035-9.

PMID:6913607
Abstract

A protein with decay-accelerating activity for the classical C3 convertase, C4b2a, has been isolated on the basis of this function from guinea pig erythrocyte stroma. The isolation procedure for decay-accelerating factor of stroma (DAF-S) utilizes butanol extraction and chromatography on DEAE-Sephacel, hydroxylapatite, and phenyl Sepharose. Purified DAF-S has a m.w. of 60,000 and 65,000 on reduced and unreduced SDS gels, respectively, and exhibits m.w. of 30,000 and 175,000 on alkaline gradient gels, suggesting multiples of a 60,000-65,000 subunit. Purified DAF-S elicited a monospecific antiserum whose IgG fraction neutralized the decay-accelerating activity for C4b,2a affixed to 10(7) sheep erythrocytes (EAC1,4,2) in a dose-response fashion. The monospecific antiserum diluted up to 1:5120 agglutinated 1 x 10(6) guinea pig erythrocytes, but not sheep or human erythrocytes, suggesting that DAF-S, an integral membrane protein, has species-specific antigens that are expressed on the surface of the guinea pig erythrocyte.

摘要

基于经典C3转化酶C4b2a的衰变加速活性,已从豚鼠红细胞基质中分离出一种蛋白质。基质衰变加速因子(DAF-S)的分离过程采用丁醇提取以及在DEAE-葡聚糖凝胶、羟基磷灰石和苯基琼脂糖上进行色谱分离。纯化后的DAF-S在还原和非还原SDS凝胶上的分子量分别为60,000和65,000,在碱性梯度凝胶上的分子量分别为30,000和175,000,表明是一个60,000 - 65,000亚基的倍数。纯化后的DAF-S引发了一种单特异性抗血清,其IgG组分以剂量反应方式中和了附着在10⁷个绵羊红细胞(EAC1,4,2)上的C4b,2a的衰变加速活性。稀释至1:5120的单特异性抗血清可凝集1×10⁶个豚鼠红细胞,但不能凝集绵羊或人类红细胞,这表明作为一种整合膜蛋白的DAF-S具有在豚鼠红细胞表面表达的物种特异性抗原。

相似文献

1
Purification from guinea pig erythrocyte stroma of a decay-accelerating factor for the classical c3 convertase, C4b,2a.从豚鼠红细胞基质中纯化经典C3转化酶C4b,2a的衰变加速因子。
J Immunol. 1981 Nov;127(5):2035-9.
2
Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.经典途径激活的表面调节:绵羊、豚鼠和人红细胞上C2和C3转化酶的形成与调节
J Immunol. 1983 Jul;131(1):403-8.
3
Isolation of C4-binding protein from guinea pig plasma and demonstration of its function as a control protein of the classical complement pathway C3 convertase.从豚鼠血浆中分离C4结合蛋白,并证明其作为经典补体途径C3转化酶控制蛋白的功能。
J Immunol. 1981 Jan;126(1):232-5.
4
Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system.一种对补体系统C3转化酶具有衰变加速活性的人红细胞膜糖蛋白的分离。
J Immunol. 1982 Jul;129(1):184-9.
5
Murine membrane inhibitor of complement which accelerates decay of human C3 convertase.加速人C3转化酶衰变的小鼠补体膜抑制剂。
Immunology. 1989 Dec;68(4):439-44.
6
Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.衰变加速因子(DAF)整合到细胞膜后对细胞表面补体激活的抑制作用。
J Exp Med. 1984 Nov 1;160(5):1558-78. doi: 10.1084/jem.160.5.1558.
7
The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb.衰变加速因子(DAF)的作用机制。DAF通过解离C2a和Bb来抑制C3转化酶的组装。
J Exp Med. 1987 Nov 1;166(5):1221-8. doi: 10.1084/jem.166.5.1221.
8
Effect of decay-accelerating factor on the assembly of the classical and alternative pathway C3 convertases in the presence of C4 or C3 nephritic factor.衰变加速因子在存在C4或C3肾炎因子的情况下对经典途径和替代途径C3转化酶组装的影响。
Immunology. 1989 Dec;68(4):449-52.
9
Regulation and deregulation of the fluid-phase classical pathway C3 convertase.液相经典途径C3转化酶的调节与去调节
J Immunol. 1985 Jul;135(1):440-4.
10
[Formation of classical C3 convertase during the alternative pathway of human complement activation].[人类补体激活替代途径中经典C3转化酶的形成]
Biokhimiia. 1987 Apr;52(4):660-6.

引用本文的文献

1
Decay-Accelerating Factor Differentially Associates With Complement-Mediated Damage in Synovium After Meniscus Tear as Compared to Anterior Cruciate Ligament Injury.与前交叉韧带损伤相比,半月板撕裂后滑膜中衰变加速因子与补体介导的损伤存在差异关联。
Immune Netw. 2024 Apr 29;24(2):e17. doi: 10.4110/in.2024.24.e17. eCollection 2024 Apr.
2
Application of Nanomaterials in the Prevention, Detection, and Treatment of Methicillin-Resistant (MRSA).纳米材料在耐甲氧西林金黄色葡萄球菌(MRSA)预防、检测及治疗中的应用
Pharmaceutics. 2022 Apr 6;14(4):805. doi: 10.3390/pharmaceutics14040805.
3
Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers.
红细胞:一个被忽视的载体向人工纳米载体天然母舰的蜕变。
Adv Drug Deliv Rev. 2021 Nov;178:113992. doi: 10.1016/j.addr.2021.113992. Epub 2021 Sep 29.
4
The interaction between the complement system and hemostatic factors.补体系统与止血因子的相互作用。
Curr Opin Hematol. 2020 Sep;27(5):341-352. doi: 10.1097/MOH.0000000000000605.
5
Role of Murine Complement Component C5 in Acute Infection by Pathogenic .鼠源补体成分 C5 在病原性 …… 急性感染中的作用
Front Cell Infect Microbiol. 2018 Mar 8;8:63. doi: 10.3389/fcimb.2018.00063. eCollection 2018.
6
Comparative Haploid Genetic Screens Reveal Divergent Pathways in the Biogenesis and Trafficking of Glycophosphatidylinositol-Anchored Proteins.比较单倍体遗传筛选揭示了糖基磷脂酰肌醇锚定蛋白生物合成和运输中的不同途径。
Cell Rep. 2015 Jun 23;11(11):1727-36. doi: 10.1016/j.celrep.2015.05.026. Epub 2015 Jun 11.
7
Successful use of eculizumab in an 86-year-old patient with paroxysmal nocturnal hemoglobinuria in Japan.依库珠单抗在日本一名86岁阵发性夜间血红蛋白尿患者中的成功应用。
Springerplus. 2014 Jan 4;3:10. doi: 10.1186/2193-1801-3-10.
8
The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55).肠道病毒70的海拉细胞受体是衰变加速因子(CD55)。
J Virol. 1996 Aug;70(8):5143-52. doi: 10.1128/JVI.70.8.5143-5152.1996.
9
Membrane proteins that protect against complement lysis.防止补体溶解的膜蛋白。
Springer Semin Immunopathol. 1994;15(4):369-96. doi: 10.1007/BF01837366.
10
Cell-surface bound complement regulatory activity is necessary for the in vivo survival of KDH-8 rat hepatoma.细胞表面结合的补体调节活性对于KDH - 8大鼠肝癌细胞在体内存活是必需的。
Immunology. 1994 Aug;82(4):522-8.